Developer docs
API playgroundTry for free, no card

Search company profiles

sanford burnham medical research institute

Full company profile

uuid02m6dfk

Namestring
sanford burnham medical research institute
Legal namestring
Sanford Burnham Prebys Medical Discovery Institute
Company typeenum
Private
Founded yearint
1976
Descriptiontext

Sanford Burnham Prebys is a nonprofit 501(c)(3) biomedical research institute headquartered in La Jolla, California, founded in 1976 as the La Jolla Cancer Research Foundation and renamed through successive mergers and benefactor partnerships (T. Denny Sanford in 2010, Prebys Foundation in 2019). It operates four disease-focused research centers — NCI-Designated Cancer Center (one of only eight NCI-designated Basic Laboratory Cancer Centers in the U.S.), Center for Cardiovascular and Muscular Diseases, Center for Neurologic Diseases, and Center for Metabolic and Liver Diseases — supported by three enabling-technology centers: the Center for Therapeutics Discovery, the Conrad Prebys Center for Chemical Genomics (high-throughput screening of up to 750,000 compounds using acoustic dispensing in 1,536-well parallel arrays), and the Center for Data Science and Artificial Intelligence.

The institute runs a Graduate School of Biomedical Sciences and a Postdoctoral Training Program alongside supplementary training tracks including CIRM, LEAP, internships, and international services. Research outputs are translated into health impact through technology licensing and partnering with pharmaceutical and biotech companies, federal research collaboration with NIH and international health agencies (notably a 2026 nonbinding partnership with the Abu Dhabi Department of Health), and publication in peer-reviewed journals.

Revenue is generated from four streams: federal research funding (primarily NIH/NCI grants), philanthropy and donations (with the institute claiming 90 cents of every dollar goes directly to research), licensing and royalty income from licensed intellectual property, and educational program tuition and stipends. The institute is governed by a Board of Directors with no parent company and operates as an independent private nonprofit rather than a commercial enterprise.

Short descriptiontext

Sanford Burnham Prebys is a nonprofit biomedical research institute in La Jolla conducting fundamental and translational research across cancer, cardiovascular, neurologic, and metabolic diseases, with high-throughput drug screening, computational biology, and graduate and postdoctoral training programs funded primarily by NIH grants and philanthropy.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersLa Jolla, United States
HQ citystring
La Jolla
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomedical research, drug discovery, cancer research, high-throughput screening, graduate science education
Industry3 codes
1Preclinical CROs (Discovery/Pharmacology/DMPK)
CodeHLAGAAABPrimaryYes
2Nonclinical Study Management & Regulatory Writing (IND-enabling)
CodeHLAGAFANPrimaryNo
3Transcriptomics & Gene Expression Profiling Services
CodeHLAGANAEPrimaryNo
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Biomedical Research
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Federal Research Funding
TypeSubscription Recurring
Description

Primary revenue from NIH and other federal research grants. The institute actively advocates for federal research funding and opposes policies threatening indirect cost reimbursement.

sbpdiscovery.org
2Philanthropy and Donations
TypeOthers
Description

Nine out of every 10 dollars invested at Sanford Burnham Prebys directly funds research. Major philanthropist T. Denny Sanford was a key benefactor. Multiple giving programs including one-time donations, legacy giving, and recurring support.

sbpdiscovery.org
3Licensing and Technology Transfer
TypeLicensing Royalties
Description

Revenue from licensing intellectual property, technologies, and collaboration opportunities developed by researchers to pharmaceutical and biotech companies.

sbpdiscovery.org
4Educational Programs
TypeProfessional Services
Description

Graduate school, postdoctoral training, and internship programs that provide training while generating revenue through tuition and stipends.

sbpdiscovery.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Sanford Burnham Prebys is an independent nonprofit biomedical research institute that conducts basic and translational research across cancer, cardiovascular, neurologic, and metabolic diseases through six specialized research centers. The institute translates scientific discoveries into drug candidates using high-throughput chemical screening, computational biology, and AI, and licenses resulting technologies to pharmaceutical and biotech partners. It also operates a Graduate School of Biomedical Sciences and postdoctoral training programs to develop the next generation of scientific leaders.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Sanford Burnham Prebys is a research institute organized around a platform of six interconnected research centers focused on disease areas and enabling technologies. Four disease-focused centers target cancer, cardiovascular/muscular, neurologic, and metabolic disease. They are supported by three enabling technologies centers: Center for Data Science and Artificial Intelligence (computational biology, machine learning, AI), Center for Therapeutics Discovery (drug discovery), and the Conrad Prebys Center for Chemical Genomics (high-throughput chemical screening with robotics and acoustic dispensing). The institute also offers educational programs (Graduate School, Postdoctoral Training) and technology transfer services through licensing and partnering opportunities. Research programs include Cancer Metabolism and Microenvironment and Cancer Genome and Epigenetics, with overarching themes in Aging, Immunity/Inflammation/Microbiology, Stem Cells/Regenerative Medicine, and Children's Health.

Product and service10 records
1NCI-Designated Cancer Center
CategoryResearch Center
2Center for Cardiovascular and Muscular Diseases
CategoryResearch Center
3Center for Neurologic Diseases
CategoryResearch Center
4Center for Metabolic and Liver Diseases
CategoryResearch Center
5Center for Data Science and Artificial Intelligence
CategoryResearch Center
6Center for Therapeutics Discovery
CategoryResearch Center
7Conrad Prebys Center for Chemical Genomics
CategoryResearch Sub-Center
8Graduate School of Biomedical Sciences
CategoryEducation Program
9Postdoctoral Training Program
CategoryEducation Program
10Licensing and Partnering Opportunities
CategoryTechnology Transfer Service
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Department of Health in Abu Dhabi
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-08-06
Description

Nonbinding pact between Sanford Burnham Prebys Medical Discovery Institute and the Department of Health in Abu Dhabi. The partnership is intended to expand and accelerate biomedical research in both nations, fostering international scientific collaboration and knowledge exchange in healthcare and life sciences.

sbpdiscovery.org
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Nonprofit research organization with major programs in brain science, cell science, and AI-driven biological data platforms. Comparable as a nonprofit research entity investing heavily in data science and AI infrastructure for biomedical discovery.

TypeDirect peer
Description

Nonprofit research institute integrating genomics, chemical biology, and computational science for disease research. Comparable in combining high-throughput chemistry, multi-omics, and AI capabilities within a nonprofit research structure.

TypeDirect peer
Description

UCSF-affiliated nonprofit research organization focused on disease-oriented biomedical discovery in cardiovascular, neurological, and viral/immunological areas. Direct comparable in mission, scale, and translational research positioning.

TypeDirect peer
Description

Nonprofit basic biomedical research institute focused on gene regulation, regeneration, and cancer. Comparable in mission, scale, and privately funded nonprofit research model.

TypeDirect peer
Description

Nonprofit genetics and genomics research institute with significant preclinical model and disease research programs. Comparable in disease-research focus, nonprofit funding model, and translational/educational offerings.

TypeDirect peer
Description

La Jolla-based translational biomedical research institute with strong drug discovery and graduate programs. Most directly comparable peer — same geographic cluster, similar nonprofit model, and overlapping translational research mission including high-throughput screening.

TypeDirect peer
Description

Adjacent La Jolla nonprofit biomedical research institute focused on cancer, neuroscience, aging, and immunology. Comparable scale, same operating model, and shares the La Jolla talent ecosystem and funding base.

TypeBroad incumbent
Description

Larger, established biomedical research organization funding hundreds of investigators across U.S. institutions. Comparable nonprofit biomedical research funder/operator but operates at significantly greater scale and primarily through an investigator-network model rather than a single campus.

TypeDirect peer
Description

Seattle-based NCI-designated cancer center with strong basic and translational research programs. Comparable in NCI designation, scale, and integration of research with training/clinical translation in oncology.

TypeDirect peer
Description

Nonprofit research and educational institution with strengths in cancer biology, neuroscience, and quantitative biology. Comparable scale, nonprofit status, and educational/training programs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

sanford burnham medical research institute

Biomedical Researchsanfordburnham.org

Sanford Burnham Prebys is a nonprofit biomedical research institute in La Jolla conducting fundamental and translational research across cancer, cardiovascular, neurologic, and metabolic diseases, with high-throughput drug screening, computational biology, and graduate and postdoctoral training programs funded primarily by NIH grants and philanthropy.

What sanford burnham medical research institute does

Sanford Burnham Prebys is a nonprofit 501(c)(3) biomedical research institute headquartered in La Jolla, California, founded in 1976 as the La Jolla Cancer Research Foundation and renamed through successive mergers and benefactor partnerships (T. Denny Sanford in 2010, Prebys Foundation in 2019). It operates four disease-focused research centers — NCI-Designated Cancer Center (one of only eight NCI-designated Basic Laboratory Cancer Centers in the U.S.), Center for Cardiovascular and Muscular Diseases, Center for Neurologic Diseases, and Center for Metabolic and Liver Diseases — supported by three enabling-technology centers: the Center for Therapeutics Discovery, the Conrad Prebys Center for Chemical Genomics (high-throughput screening of up to 750,000 compounds using acoustic dispensing in 1,536-well parallel arrays), and the Center for Data Science and Artificial Intelligence.

The institute runs a Graduate School of Biomedical Sciences and a Postdoctoral Training Program alongside supplementary training tracks including CIRM, LEAP, internships, and international services. Research outputs are translated into health impact through technology licensing and partnering with pharmaceutical and biotech companies, federal research collaboration with NIH and international health agencies (notably a 2026 nonbinding partnership with the Abu Dhabi Department of Health), and publication in peer-reviewed journals.

Revenue is generated from four streams: federal research funding (primarily NIH/NCI grants), philanthropy and donations (with the institute claiming 90 cents of every dollar goes directly to research), licensing and royalty income from licensed intellectual property, and educational program tuition and stipends. The institute is governed by a Board of Directors with no parent company and operates as an independent private nonprofit rather than a commercial enterprise.

sanford burnham medical research institute firmographics

Firmographics
Name
sanford burnham medical research institute
Legal name
Sanford Burnham Prebys Medical Discovery Institute
Website
https://sanfordburnham.org
Company type
Private
Founded year
1976
Operating status
Operating
Short description
Sanford Burnham Prebys is a nonprofit biomedical research institute in La Jolla conducting fundamental and translational research across cancer, cardiovascular, neurologic, and metabolic diseases, with high-throughput drug screening, computational biology, and graduate and postdoctoral training programs funded primarily by NIH grants and philanthropy.
Ownership category
akta.pro rank

sanford burnham medical research institute industry classification

Industry
Product category
Biomedical Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)
akta.pro secondary industries
Nonclinical Study Management & Regulatory Writing (IND-enabling) (HLAGAFAN), Transcriptomics & Gene Expression Profiling Services (HLAGANAE)

Keywords

  • Biomedical research
  • Drug discovery
  • Cancer research
  • High-throughput screening
  • Graduate science education

Where sanford burnham medical research institute is headquartered

Location

Headquarters

HQ city
La Jolla
HQ country
United States
HQ region
North America

Offices1 record

Markets served

sanford burnham medical research institute business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Federal Research Funding: Primary revenue from NIH and other federal research grants. The institute actively advocates for federal research funding and opposes policies threatening indirect cost reimbursement.
  2. Philanthropy and Donations: Nine out of every 10 dollars invested at Sanford Burnham Prebys directly funds research. Major philanthropist T. Denny Sanford was a key benefactor. Multiple giving programs including one-time donations, legacy giving, and recurring support.
  3. Licensing and Technology Transfer: Revenue from licensing intellectual property, technologies, and collaboration opportunities developed by researchers to pharmaceutical and biotech companies.
  4. Educational Programs: Graduate school, postdoctoral training, and internship programs that provide training while generating revenue through tuition and stipends.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

sanford burnham medical research institute product offering

Product offering

Core offering

Sanford Burnham Prebys is an independent nonprofit biomedical research institute that conducts basic and translational research across cancer, cardiovascular, neurologic, and metabolic diseases through six specialized research centers. The institute translates scientific discoveries into drug candidates using high-throughput chemical screening, computational biology, and AI, and licenses resulting technologies to pharmaceutical and biotech partners. It also operates a Graduate School of Biomedical Sciences and postdoctoral training programs to develop the next generation of scientific leaders.

Product overview

Sanford Burnham Prebys is a research institute organized around a platform of six interconnected research centers focused on disease areas and enabling technologies. Four disease-focused centers target cancer, cardiovascular/muscular, neurologic, and metabolic disease. They are supported by three enabling technologies centers: Center for Data Science and Artificial Intelligence (computational biology, machine learning, AI), Center for Therapeutics Discovery (drug discovery), and the Conrad Prebys Center for Chemical Genomics (high-throughput chemical screening with robotics and acoustic dispensing). The institute also offers educational programs (Graduate School, Postdoctoral Training) and technology transfer services through licensing and partnering opportunities. Research programs include Cancer Metabolism and Microenvironment and Cancer Genome and Epigenetics, with overarching themes in Aging, Immunity/Inflammation/Microbiology, Stem Cells/Regenerative Medicine, and Children's Health.

Differentiator

Problem solved

Functional benefit

Products and services

  • NCI-Designated Cancer Center
  • Center for Cardiovascular and Muscular Diseases
  • Center for Neurologic Diseases
  • Center for Metabolic and Liver Diseases
  • Center for Data Science and Artificial Intelligence
  • Center for Therapeutics Discovery
  • Conrad Prebys Center for Chemical Genomics
  • Graduate School of Biomedical Sciences
  • Postdoctoral Training Program
  • Licensing and Partnering Opportunities

Companies that use sanford burnham medical research institute

Customer profile

Segments4 records

Ideal customer profiles4 records

sanford burnham medical research institute technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

sanford burnham medical research institute partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Department of Health in Abu DhabicoreStrategic or Co-development Partner · 6 August 2026Nonbinding pact between Sanford Burnham Prebys Medical Discovery Institute and the Department of Health in Abu Dhabi. The partnership is intended to expand and accelerate biomedical research in both nations, fostering international scientific collaboration and knowledge exchange in healthcare and life sciences.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

sanford burnham medical research institute competitors and assessment

Company assessment

Direct peers

  • Allen Institute: Nonprofit research organization with major programs in brain science, cell science, and AI-driven biological data platforms. Comparable as a nonprofit research entity investing heavily in data science and AI infrastructure for biomedical discovery.
  • Broad Institute of MIT and Harvard: Nonprofit research institute integrating genomics, chemical biology, and computational science for disease research. Comparable in combining high-throughput chemistry, multi-omics, and AI capabilities within a nonprofit research structure.
  • Gladstone Institutes: UCSF-affiliated nonprofit research organization focused on disease-oriented biomedical discovery in cardiovascular, neurological, and viral/immunological areas. Direct comparable in mission, scale, and translational research positioning.
  • Stowers Institute for Medical Research: Nonprofit basic biomedical research institute focused on gene regulation, regeneration, and cancer. Comparable in mission, scale, and privately funded nonprofit research model.
  • The Jackson Laboratory: Nonprofit genetics and genomics research institute with significant preclinical model and disease research programs. Comparable in disease-research focus, nonprofit funding model, and translational/educational offerings.
  • Scripps Research: La Jolla-based translational biomedical research institute with strong drug discovery and graduate programs. Most directly comparable peer — same geographic cluster, similar nonprofit model, and overlapping translational research mission including high-throughput screening.
  • Salk Institute for Biological Studies: Adjacent La Jolla nonprofit biomedical research institute focused on cancer, neuroscience, aging, and immunology. Comparable scale, same operating model, and shares the La Jolla talent ecosystem and funding base.
  • Fred Hutchinson Cancer Center: Seattle-based NCI-designated cancer center with strong basic and translational research programs. Comparable in NCI designation, scale, and integration of research with training/clinical translation in oncology.
  • Cold Spring Harbor Laboratory: Nonprofit research and educational institution with strengths in cancer biology, neuroscience, and quantitative biology. Comparable scale, nonprofit status, and educational/training programs.

Broad incumbents

  • Howard Hughes Medical Institute: Larger, established biomedical research organization funding hundreds of investigators across U.S. institutions. Comparable nonprofit biomedical research funder/operator but operates at significantly greater scale and primarily through an investigator-network model rather than a single campus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

sanford burnham medical research institute social profiles

Digital presence

sanford burnham medical research institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

sanford burnham medical research institute leadership team

Management profile

Number of profiles

Profiles1 record

sanford burnham medical research institute funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

sanford burnham medical research institute M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about sanford burnham medical research institute

What does sanford burnham medical research institute do?

Sanford Burnham Prebys is an independent nonprofit biomedical research institute that conducts basic and translational research across cancer, cardiovascular, neurologic, and metabolic diseases through six specialized research centers. The institute translates scientific discoveries into drug candidates using high-throughput chemical screening, computational biology, and AI, and licenses resulting technologies to pharmaceutical and biotech partners. It also operates a Graduate School of Biomedical Sciences and postdoctoral training programs to develop the next generation of scientific leaders.

Is sanford burnham medical research institute a public or private company?

sanford burnham medical research institute is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was sanford burnham medical research institute founded?

sanford burnham medical research institute was founded in 1976.

Where is sanford burnham medical research institute based?

sanford burnham medical research institute is headquartered in La Jolla, United States, in the North America region.

How does sanford burnham medical research institute make money?

Four revenue lines are on record. Federal Research Funding is the primary driver. The others are philanthropy and Donations, licensing and Technology Transfer and educational Programs.

Who are sanford burnham medical research institute's main competitors?

Direct peers on record are Allen Institute, Broad Institute of MIT and Harvard, Gladstone Institutes, Stowers Institute for Medical Research, The Jackson Laboratory, Scripps Research, Salk Institute for Biological Studies, Fred Hutchinson Cancer Center and Cold Spring Harbor Laboratory. Howard Hughes Medical Institute is listed as a broad incumbent.

Does sanford burnham medical research institute have an API?

No public API is recorded for sanford burnham medical research institute.

What industry is sanford burnham medical research institute in?

sanford burnham medical research institute's product category is Biomedical Research. Its primary akta.pro industry code is HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK), with a secondary code of HLAGAFAN, Nonclinical Study Management & Regulatory Writing (IND-enabling). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
News-MedicalCell proliferation gene plays a distinct role in cells that no longer proliferateResearchers at Sanford Burnham Prebys Medical Discovery Institute, with collaborators, published findings in Nature Aging on August 20, 2026 showing that the cancer-linked cyclin D1 gene drives chronic inflammation in senescent cells. In mice, blocking cyclin D1 with palbociclib reduced DNA damage, inflammatory gene expression, frailty and motor decline. The team plans further exploration of repurposing such drugs for age-related inflammatory disease.Mirage NewsCell Cycle Regulator's Secret Role in Non-Cycling CellsResearchers at Sanford Burnham Prebys Medical Discovery Institute and collaborators published findings in Nature Aging on August 20, 2026, showing that cyclin D1, a cancer-linked gene, drives chronic inflammation in senescent cells. In aged mice, blocking cyclin D1 with palbociclib reduced DNA damage, suppressed frailty and improved motor function. The team says repurposing such drugs for age-related inflammatory disease warrants further exploration.GenengnewsProtein Protects Against Tau Tangles, Synaptic Loss in Mouse Model of TauopathyResearchers at Sanford Burnham Prebys found that overexpressing the protein SORLA in a mouse model of tauopathy reduced tau tangles, synaptic loss, and brain atrophy. Conversely, deleting SORLA worsened these effects. The team plans further studies to explore cell-specific effects and potential drug repurposing.KarlobagRNA pollution and new research into brain agingResearchers from UC San Diego, Salk Institute, and Sanford Burnham Prebys received a $13 million, four-year grant to study RNA pollution in neurons. The project aims to identify age-related RNA disruptions that may contribute to Alzheimer's, Parkinson's, and ALS, using induced neurons and drug screening. If successful, it could shift therapy toward preserving neuronal resilience before disease onset.News-MedicalScientists seek to reverse neurodegeneration by eliminating harmful RNA pollutionResearchers at UC San Diego, Salk, and Sanford Burnham Prebys received a $13 million, four-year CIRM award to study age-related neurodegeneration by eliminating RNA pollution in aging neurons. The team will map RNA pollution signatures across 200+ cell lines and screen thousands of treatments, including FDA-approved drugs and RNA therapies, to develop new therapies for Alzheimer's, Parkinson's, and ALS.GlobeNewswireBionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing TechnologiesBionano announced a study published in Molecular Therapy describing optical genome mapping (OGM) for detecting genomic alterations from gene editing technologies. The study found transposons and lentiviral transduction caused more insertions than CRISPR-Cas9, and OGM outperformed traditional methods in detecting complex structural variants.CaminopharmaDecember 7, 2023 Press ReleaseCamino Pharma, LLC has received a $1.97 million grant from the National Institute on Alcohol Abuse and Alcoholism to develop therapies for alcohol use disorder. The grant funds a collaboration with Sanford Burnham Prebys and Wake Forest University to evaluate potential treatments in rodent models. This effort represents a significant advancement in developing novel therapeutic options for patients with alcohol dependence.BioSpaceCamino Pharma receives $1.97M Small Business Innovation Research (SBIR) Grant from the National Institute of Alcohol Abuse and AlcoholismCamino Pharma, LLC has been awarded a $1.97 million grant from the National Institute on Alcohol Abuse and Alcoholism to validate positive allosteric modulators for treating alcohol use disorder. The funding will support a collaborative research effort with Sanford Burnham Prebys and Wake Forest University School of Medicine using rodent models to assess efficacy. This development marks a step toward advancing these novel therapeutic candidates into clinical trials.GlobeNewswireSanford Burnham Prebys and Roivant Social Ventures Announce Groundbreaking Partnership to Increase Diversity & Inclusion in BiopharmaSanford Burnham Prebys and Roivant Social Ventures announced a partnership to train diverse biopharma leaders, addressing diversity gaps and shelved drugs. The program provides hands-on drug development experience, with Sanford Burnham Prebys offering lab access and Roivant Social Ventures supporting drug candidate identification and incubation.GlobeNewswireCalifornia Life Sciences Association (CLSA) Adds Leaders from Genentech, Sanford Burnham Prebys Medical Discovery Institute and OncoCyte to Board of DirectorsCalifornia Life Sciences Association appointed three new board members: William Annett of OncoCyte, Perry Nisen of Sanford Burnham Prebys, and James Sabry of Genentech. The appointments aim to strengthen CLSA's advocacy for California's life sciences sector, which employs nearly 300,000 people across 2,800 organizations.